AHRP Ethical and Scientific Objections to FDA’s Proposed Licensure of Anthrax Vaccine

When a federal judge ruled the vaccine to be an "investigational drug and a drug being used for an unapproved purpose" on December 22, 2003, FDA hurriedly issued a Final Rule for anthrax vaccine. The agency submitted its Final Rule just eight days after a federal court injunction, having failed to do so for 19 years. In a January 7, 2004 court hearing the same judge called FDA’s actions "highly suspicious." On October 27, 2004 FDA’s arbitrary and capricious promulgation of this Final Rule resulted in a permanent injunction, remanding the license to your agency to complete according to the law. The injunction also halted what the judge called DoD’s "illegal" mandatory anthrax vaccination program.

| | |

Dying to be Famous? Shooting Fuels Debate Over Safety of Prozac for Teens

Dying to be Famous? Shooting Fuels Debate Over Safety of Prozac for Teens Sun, 27 Mar 2005 An Op Ed in The New York Times by Lionel Shriver (from London), dismisses the notion promulgated by the mental health industry–which is under the influence of drug companies–that “early signs” in troubled…

Minnesota Attorney General Supports Widow in Zoloft Suicide Case

Minnesota Attorney General Supports Widow in Zoloft Suicide Case Tue, 22 Mar 2005 A press release from the law firm, Baum Hedlund announces that Minnesota’s State Attorney General filed a legal brief refuting Pfizer’s claim that “it should be immune from liability for failing to warn about dangerous side effects…

US Marshals Seize Millions of Defective Paxil & Avandamet pills – NYT

US Marshals Seize Millions of Defective Paxil & Avandamet pills_NYT Mon, 7 Mar 2005 The FDA and federal marshals yanked millions of tablets of the antidepressant, Paxil CR (Seroxat, controlled release) and the diabetes drug, Avandamet, off the market because they are defective. The Paxil pills split during manufacturing, and…

Pfizer Marketing Scheme Stirs Concern/ Corporate Responsibility Movement Puts PhRMA on Notice

Pfizer Marketing Scheme Stirs Concern_NYT / Corporate Responsibility Movement Puts PhRMA on Notice_ ICCR Mon, 7 Mar 2005 The New York Times reports that Pfizer is planning to lock up the market for heart treaments by bundling its new drug (toretrapib, which is still in experimental stage of development) to…

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT Thu, 17 Feb 200 A three day public advisory panel hearing which is overflowing with attendees from around the world, is an investigation of the conduct of pharmaceutical company giants and the FDA. The hearing began…

Testimony of Meryl Nass, MD – Senate HELP Committee, Subcommittee on Bioterrorism

Thank you for the opportunity to submit this testimony for the record.

My name is Meryl Nass, M.D., and I have worked for the past twenty years as an emergency physician and internist in community hospitals in the northeastern US. I have also studied many aspects of bioterrorism since 1989. I am the person who first demonstrated, in 1992, that one could investigate an epidemic retrospectively, and prove that it was due to biological warfare, using Rhodesia’s 1978-80 anthrax epidemic as a model.[1]

Examination of Eli Lilly’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance

Peter R. Breggin, M.D. 101 East State Street, No. 112 Ithaca, New York 14850 www.breggin.com Phone: 607 272 5328 Fax: 607 272 5329 January 12, 2005 An Examination of Eli Lilly and Company’s Contentions that the BMJ Prozac Documents were Never Missing and Have No Significance A report by Peter…